These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7886804)

  • 1. Rejection of kidney allografts by MHC class I-deficient mice.
    Mannon RB; Nataraj C; Kotzin BL; Griffiths R; Geier S; Ibrahim S; Sanfilippo FP; Platt JL; Kurlander R; Coffman TM
    Transplantation; 1995 Mar; 59(5):746-55. PubMed ID: 7886804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection.
    Mannon RB; Griffiths R; Ruiz P; Platt JL; Coffman TM
    Kidney Int; 2002 Jul; 62(1):290-300. PubMed ID: 12081591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.
    Mannon RB; Kotzin BL; Nataraj C; Ferri K; Roper E; Kurlander RJ; Coffman TM
    J Clin Invest; 1998 Jun; 101(11):2517-27. PubMed ID: 9616223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
    Gracie JA; Bolton EM; Porteous C; Bradley JA
    J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
    He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
    Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intragraft CD8+ T cell response in renal allograft rejection in the mouse.
    Mannon RB; Kotzin BL; Roper E; Nataraj C; Kurlander RJ; Coffman TM
    Transplantation; 1996 Jul; 62(1):96-104. PubMed ID: 8693553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
    Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
    J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
    Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
    J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection.
    Gilot BJ; Hara M; Jones ND; van Maurik A; Niimi M; Hadjianastassiou V; Morris PJ; Wood KJ
    Transplantation; 2000 Feb; 69(4):639-48. PubMed ID: 10708123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease.
    Richards DM; Dalheimer SL; Hertz MI; Mueller DL
    J Immunol; 2003 Dec; 171(12):6919-28. PubMed ID: 14662899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved renal function in mouse kidney allografts lacking MHC class I antigens.
    Coffman T; Geier S; Ibrahim S; Griffiths R; Spurney R; Smithies O; Koller B; Sanfilippo F
    J Immunol; 1993 Jul; 151(1):425-35. PubMed ID: 8326135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.